Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
227.46 USD | -1.39% |
|
-4.11% | -10.35% |
Projected Income Statement: Humana Inc.
Annual
Quarterly
Annual
Quarterly
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 77,155 | 83,064 | 92,870 | 1,06,374 | 1,17,761 | 1,26,619 | 1,30,320 | 1,40,744 |
Change | - | 7.66% | 11.81% | 14.54% | 10.7% | 7.52% | 2.92% | 8% |
EBITDA 1 | 4,240 | 4,278 | 5,122 | 5,711 | 4,442 | 4,077 | 3,736 | 4,537 |
Change | - | 0.9% | 19.73% | 11.5% | -22.22% | -8.21% | -8.37% | 21.45% |
EBIT 1 | 3,751 | 2,488 | 4,413 | 4,999 | 3,543 | 3,330 | 2,973 | 3,963 |
Change | - | -33.67% | 77.37% | 13.28% | -29.13% | -6% | -10.74% | 33.32% |
Interest Paid 1 | -283 | -326 | -401 | -493 | -660 | -653.4 | -652.1 | -666.7 |
Earnings before Tax (EBT) 1 | 4,600 | 3,354 | 3,568 | 3,383 | 1,721 | 2,527 | 2,181 | 3,306 |
Change | - | -27.09% | 6.38% | -5.18% | -49.13% | 46.81% | -13.69% | 51.62% |
Net income 1 | 3,367 | 2,933 | 2,806 | 2,489 | 1,207 | 1,865 | 1,563 | 2,472 |
Change | - | -12.89% | -4.33% | -11.3% | -51.51% | 54.49% | -16.15% | 58.13% |
Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 25/01/24 | 11/02/25 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: Humana Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 1,987 | 9,100 | 6,065 | 6,962 | 9,500 | 7,572 | 6,284 | 5,765 |
Change | - | 357.98% | -33.35% | 14.79% | 36.46% | -20.29% | -17.01% | -8.26% |
Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 25/01/24 | 11/02/25 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: Humana Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 964 | 1,316 | 1,120 | 1,004 | 575 | 608.5 | 634.4 | 657.4 |
Change | - | 36.51% | -14.89% | -10.36% | -42.73% | 5.83% | 4.25% | 3.63% |
Free Cash Flow (FCF) 1 | 4,675 | 946 | 3,467 | 2,977 | 2,391 | 2,922 | 2,528 | 3,204 |
Change | - | -79.76% | 266.49% | -14.13% | -19.68% | 22.19% | -13.46% | 26.71% |
Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 25/01/24 | 11/02/25 | - | - | - |
1USD in Million
Estimates
Forecast Financial Ratios: Humana Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 5.5% | 5.15% | 5.52% | 5.37% | 3.77% | 3.22% | 2.87% | 3.22% |
EBIT Margin (%) | 4.86% | 3% | 4.75% | 4.7% | 3.01% | 2.63% | 2.28% | 2.82% |
EBT Margin (%) | 5.96% | 4.04% | 3.84% | 3.18% | 1.46% | 2% | 1.67% | 2.35% |
Net margin (%) | 4.36% | 3.53% | 3.02% | 2.34% | 1.02% | 1.47% | 1.2% | 1.76% |
FCF margin (%) | 6.06% | 1.14% | 3.73% | 2.8% | 2.03% | 2.31% | 1.94% | 2.28% |
FCF / Net Income (%) | 138.85% | 32.25% | 123.56% | 119.61% | 198.09% | 156.68% | 161.71% | 129.58% |
Profitability | ||||||||
ROA | 12.84% | 7.39% | 6.42% | 7.21% | 4.38% | 3.94% | 3.09% | 4.33% |
ROE | 19.36% | 17.92% | 20.44% | 20.57% | 12.01% | 11.57% | 9.12% | 11.7% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 0.47x | 2.13x | 1.18x | 1.22x | 2.14x | 1.86x | 1.68x | 1.27x |
Debt / Free cash flow | 0.43x | 9.62x | 1.75x | 2.34x | 3.97x | 2.59x | 2.49x | 1.8x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 1.25% | 1.58% | 1.21% | 0.94% | 0.49% | 0.48% | 0.49% | 0.47% |
CAPEX / EBITDA (%) | 22.74% | 30.76% | 21.87% | 17.58% | 12.94% | 14.92% | 16.98% | 14.49% |
CAPEX / FCF (%) | 20.62% | 139.11% | 32.3% | 33.73% | 24.05% | 20.83% | 25.09% | 20.52% |
Items per share | ||||||||
Cash flow per share 1 | 42.39 | 17.48 | 36.09 | 31.99 | 24.54 | 22.91 | 24.95 | 29.67 |
Change | - | -58.77% | 106.46% | -11.36% | -23.29% | -6.65% | 8.9% | 18.93% |
Dividend per Share 1 | 2.5 | 2.725 | 3.15 | 3.54 | 3.54 | 3.677 | 3.897 | 4.038 |
Change | - | 9% | 15.6% | 12.38% | 0% | 3.87% | 6% | 3.59% |
Book Value Per Share 1 | 106.5 | 124.3 | 122.5 | 133.1 | 135.7 | 146.2 | 154.7 | 170.3 |
Change | - | 16.65% | -1.41% | 8.6% | 2.02% | 7.72% | 5.81% | 10.1% |
EPS 1 | 25.31 | 22.67 | 22.08 | 20 | 9.98 | 15.33 | 13.04 | 20.56 |
Change | - | -10.43% | -2.6% | -9.42% | -50.1% | 53.64% | -14.94% | 57.6% |
Nbr of stocks (in thousands) | 1,32,341 | 1,28,534 | 1,26,600 | 1,23,111 | 1,20,411 | 1,20,693 | 1,20,693 | 1,20,693 |
Announcement Date | 03/02/21 | 02/02/22 | 01/02/23 | 25/01/24 | 11/02/25 | - | - | - |
1USD
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 14.8x | 17.4x |
PBR | 1.56x | 1.47x |
EV / Sales | 0.28x | 0.26x |
Yield | 1.62% | 1.71% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
227.46USD
Average target price
294.36USD
Spread / Average Target
+29.41%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HUM Stock
- Financials Humana Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition